Access the Full Agenda With 3 Days of Unrivalled Content &
20+ Industry-Leading Speakers
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2024 event, please get in touch at adc@hansonwade.com
Other Events in the Series
3rd Next-Generation Conjugates Summit February 2024 Boston, MA |
14th World ADC London March 2024 London, UK |
ADC Analytical Development Summit April 2024 Boston, MA |
Having trouble downloading the brochure? Let us know and we’ll email it to you instead
If you are going to make one correct decision during the drug development process, selecting the right target is crucial
for clinical success.
Snapshot of What You Missed:
- Gain case-study-led insights into the development of clinically validated targets from approved ADCs (Seagen, AstraZeneca) to advance your understanding of the target selection and validation requirements
- Utilize lessons on proteomics and bioinformatics to aid in your target understanding and technology selection to strengthen your therapeutic candidate and become first- or best-in-class with Innovent Biologics and Atreca
- Consider both the complex scientific and strategic factors in pipeline development, and gain an understanding of the current scope of innovation in the ADC target space with Bolt Biotherapeutics, Shanghai Miracogen, Sutro Biopharma and more
‘Excellent conference, definitely worth attending for anyone looking to learn more about targets in the context of ADCs’
Triphase Accelerator